Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Although several studies have provided evidence for the therapeutic potential of bone marrow‐derived mononuclear cells (MNCs) in animal models of stroke, the mechanisms underlying their benefits remain largely unknown. We have determined the neuroprotective potential of MNCs in primary neuronal cultures exposed to various injuries in vitro. Cortical neurons in culture were exposed to oxygen‐glucose deprivation, hypoxia, or hydrogen peroxide, and cell death was assayed by MTT, caspase‐3 activation or TUNEL labelling at 24 hrs. Cultures were randomized to cotreatment with MNC‐derived supernatants or media before injury exposure. In separate experiments, macrophage or microglial cultures were exposed to lipopolypolysacharide (LPS) in the presence and absence of MNC‐derived supernatants. Neuronal cultures were then exposed to conditioned media derived from activated macrophages or microglia. Cytokines from the supernantants of MNC cultures exposed to normoxia or hypoxia were also estimated by enzyme‐linked immunosorbant assay (ELISA). MNC‐derived supernatants attenuated neuronal death induced by OGD, hypoxia, hydrogen peroxide, and conditioned macrophage/microglial media and contain a number of trophic factors, including interleukin‐10, insulin‐like growth factor‐1, vascular endothelial growth factor, and stromal cell‐derived factor‐1. MNCs provide broad neuroprotection against a variety of injuries relevant to stroke. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317977 · Cited by 1,189
Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic
Zhang, Z. G., & Chopp, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70061-4 · Cited by 596 · cited 2×
“Cellular therapy represents a new approach to enhance recovery after stroke (Zhang and Chopp, 2009).”
Background
Cited by
Immune cell regulation of glia during CNS injury and disease
Greenhalgh, A. D., David, S., & Bennett, F. C. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0263-9 · Cited by 396
Microglial Responses after Ischemic Stroke and Intracerebral Hemorrhage
Taylor, R. A., & Sansing, L. H. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/746068 · Cited by 394
Intravenous autologous bone marrow mononuclear cells for ischemic stroke
Savitz, S. I., Misra, V., Kasam, M., Juneja, H., Cox, C. S., Alderman, S., Aisiku, I., Kar, S., Gee, A., & Grotta, J. C. (2011) · Annals of Neurology · doi:10.1002/ana.22458 · Cited by 291
Self-citationAtaka, K., Asakawa, A., Nagaishi, K., Kaimoto, K., Sawada, A., Hayakawa, Y., Tatezawa, R., Inui, A., & Fujimiya, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081744 · Cited by 89
Li, C., Chen, Y.-H., & Zhang, K. (2020) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317520927169 · Cited by 17
“They injected synthetic Ab (1-40) and Ab (1-42) into the hippocampus, which led to an increased infiltration of BMDM in the brain 72 hours after injection.”
Background
Metadata
- Authors
- Sharma, S., Yang, B., Strong, R., Xi, X., Brenneman, M., Grotta, J. C., Aronowski, J., & Savitz, S. I.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2010-08-03
- Volume
- 88
- Issue
- 13
- Pages
- 2869-2876
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2061040514
- Cited by
- 69
- References
- 2
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.